Case in Point: Big Pharma Bets on a Farm | GenomeWeb

The longer the drug development process, the more expensive a failure. AstraZeneca expects a server farm to speed up target discovery.

When Astra and Zeneca merged in 1999, Simon Weston got stuck dealing with the extra traffic. Weston manages the company’s Alderley Edge, UK, bioinformatics service for 1,000 scientists who analyze blood cells of patients with oncological and gastrointestinal diseases. Their work entails running a series of bioinformatics applications on public sequence data.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.